Novel compounds of formulae (I) to (VIII), which more particularly include sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives which are effective platelet ADP receptor inhibitors. These derivatives may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also relates to a method for preventing or treating thrombosis in a mammal comprising the step of administering a therapeutically effective amount of a compound of formulae (I) to (VIII), or a pharmaceutically acceptable salt thereof.
公式(I)至(VIII)的新化合物,其中更具体地包括磺酰
脲衍
生物、磺酰
硫脲衍
生物、磺酰
胍衍
生物、磺酰
氰基
胍衍
生物、
硫代酰基磺酰胺衍
生物和酰基磺酰胺衍
生物,这些衍
生物是有效的血小板
ADP受体
抑制剂。这些衍
生物可以用于各种药物组合物中,特别是对于预防和/或治疗心血管疾病特别有效,尤其是与血栓形成有关的疾病。本发明还涉及一种预防或治疗哺乳动物血栓形成的方法,包括给予公式(I)至(VIII)的化合物或其药学上可接受的盐的治疗有效量。